A piece in today's Streettalk section about Aquila as a corporate play. I just hope the article is correct and Poli doesn't sell out too cheaply. In years to come this company will reward all the patient holders who weren't after a quick buck.
AQA Price at posting:
$2.85 Sentiment: LT Buy Disclosure: Held